ACB-Form-FCC-Authority to Act as Agent Letter

File Info : application/pdf, 1 Pages, 28.24KB

Array
(
    [0] => Array
        (
            [url_sha] => aa5010ee09961336ee0e99c38432ad8415cc1a0fdde66ff624b56c57e6ce8c85
            [source] => fccid
            [url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=6863119
            [href_text] => ACB-Form-FCC-Authority to Act as Agent Letter
            [href_description] => EPS Bio Technology Corp. D071 Blood Glucose Monitoring System 2AQBR-D071 2AQBRD071 d071
            [http_status] => 200
            [http_lastmod] => 0000-00-00 00:00:00
            [http_contenttype] => application/pdf
            [http_filename] => GetApplicationAttachment.html?id=6863119
            [http_size] => 28919
            [file_sha256] => e2845c48f9161f2a49d63e7875d182a6e7c171865bdfa33c80f02e8d40ebb29b
            [domain] => document.fccid
        )

)

Array
(
    [0] => Array
        (
            [id] => 6863119
            [file_sha256] => 
            [applicationId] => KlR2g9fe9ctP/XlBTDzsiA==
            [description] => ACB-Form-FCC-Authority to Act as Agent Letter
            [shortTermConfidential] => No
            [permanentConfidential] => No
            [supercede] => No
            [exhibitType] => Cover Letter(s)
            [fileType] => Adobe Acrobat PDF
            [displayType] => pdf
            [fileSize] => 28921
            [submissionDate] => 2023-10-18 00:00:00
            [dateAvailable] => 2023-10-19 00:00:00
            [creationDate] => 
            [producer] => 
            [modDate] => 
            [title] => 
            [creator] => 
            [author] => 
            [pages] => 
            [realSize] => 
            [html] => 0
            [png] => 0
            [txt] => 0
            [version] => 0
            [source] => 0
            [fccId] => 2AQBR-D071
            [cleanFccId] => 2AQBRD071
            [exif] => 0
        )

)